Viridian Therapeutics, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US92790C1045

USD

32.46

2.03 (6.67%)

Dec 04

NAS

Click here to see other stocks

Viridian Therapeutics, Inc. VS Pharmaceuticals & Biotechnology

6.67%

0.3%

2.33%

0.54%

40.22%

-0.03%

YTD

69.33%

16.46%

61.57%

13.22%

18.04%

68.23%

95.54%

86.81%

10Y

95.54%

234.19%

Stock Absolute Returns
S&P 500Absolute Returns

Price + Dividend

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

66.72%

6 Months

124.64%

1 Year

61.57%

2 Years

88.5%

3 Years

18.04%

4 Years

72.29%

5 Years

95.54%

Viridian Therapeutics, Inc. for the last several years.

Risk Adjusted Returns v/s S&P 500